BPC-157 / TB-500 Blend

This is a single research vial holding equal amounts of BPC-157 and TB-500, so two repair-related signals can be studied together.

It interests recovery researchers wanting to see how collagen-building (BPC-157) and cell-movement (TB-500) pathways might complement each other.

Cell-culture studies check whether the two pathways add up. No combined human results exist — any benefit is unproven.

Distinguishes established clinical findings from early human trials, animal experiments, or laboratory cell culture findings. No human dosing, injection instructions, or treatment recommendations are provided.

This blend is an unapproved investigational mixture. It is not for human or animal medical use.

BBOHC LABS research reagents are non-clinical materials. An FDA approval for a finished medicine containing the same active ingredient does not imply that BBOHC's investigational research vial is FDA-approved.

Risks match each component peptide. Handle per biosafety protocols.

• Comparative literature on BPC-157 and Thymosin Beta-4 in musculoskeletal repair models.

Specific citations are provided for literature context. Product purity & lot verification documentation available on request.